OTC
ALXN

Opera Trading Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Opera Trading Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,002
Closed -$278K – 175
2018
Q3 		$278K Buy
+2,002
New +$251K 0.05% 103
2016
Q3 		– Sell
-233
Closed -$27K – 130
2016
Q2 		$27K Sell
233
-168
-42% -$23.8K 0.01% 113
2016
Q1 		$55K Buy
401
+300
+297% +$44K 0.01% 116
2015
Q4 		$19K Buy
+101
New +$17.6K ﹤0.01% 101

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Opera Trading Capital's ALXN Position: Q4 2018 in Review

Opera Trading Capital sold out of Alexion Pharmaceuticals (ALXN) in Q4 2018, closing a stake of 2,002 shares — an estimated $278K sold.

Opera Trading Capital first reported a position in ALXN in Q4 2015 and held it in 4 quarters. The position peaked at $278K in Q3 2018. 608 funds tracked by Wall St. Rank hold ALXN as of Q4 2018.

  • Opera Trading Capital reported no remaining Alexion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Opera Trading Capital sold 2,002 Alexion Pharmaceuticals shares in Q4 2018, an estimated $278K.
  • Opera Trading Capital first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Opera Trading Capital's Alexion Pharmaceuticals position peaked at $278K in Q3 2018.
  • 608 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2018.

Based on Opera Trading Capital's 13F filing for Q4 2018, filed 22 Jan 2019.